Halozyme Therapeutics reported $117.84M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
DBV Technologies DBVT:US 44.96M 912K
Acadia Pharmaceuticals ACAD:US $ 204.92M 57.48M
Agios Pharmaceuticals AGIO:US $ 80.03M 123.1M
Alnylam Pharmaceuticals ALNY:US $ 534.08M 285.89M
Amarin AMRN:US $ 219.15M 0.3M
Amgen AMGN:US $ 6528M 1461M
Aptinyx Inc APTX:US $ 100.16M 5.96M
Baxter International BAX:US $ 2294M 657M
Cara Therapeutics CARA:US $ 21.36M 7.91M
Cytokinetics CYTK:US $ 115.42M 2.76M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Esperion Therapeutics ESPR:US $ 150.36M 58.53M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Immunogen IMGN:US $ 437.66M 41.09M
Intercept Pharmaceuticals ICPT:US $ 48.32M 36.39M
Intra Cellular Therapies ITCI:US $ 129.29M 36.93M
Intrexon XON:US $ 40.32M 2.6M
Mannkind MNKD:US $ 67.24M 56.94M
Minerva Neurosciences NERV:US $ 54.95M 5.81M
Nektar Therapeutics NKTR:US $ 67.99M 42.78M
Peregrine Pharmaceuticals PPHM:US $ 126.17M 23.79M
Pfizer PFE:US $ 2470M 526M
Rigel Pharmaceuticals RIGL:US $ 24.68M 5.79M
United Therapeutics UTHR:US $ 813.3M 81.5M
Vanda Pharmaceuticals VNDA:US $ 66.93M 14.86M